当前位置:
X-MOL 学术
›
Lancet Haematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance
The Lancet Haematology ( IF 24.7 ) Pub Date : 2022-05-18 , DOI: 10.1016/s2352-3026(22)00139-9 Sangeetha Venugopal 1 , John Mascarenhas 2
The Lancet Haematology ( IF 24.7 ) Pub Date : 2022-05-18 , DOI: 10.1016/s2352-3026(22)00139-9 Sangeetha Venugopal 1 , John Mascarenhas 2
Affiliation
Abstract not available
中文翻译:
鲁索替尼用于对羟基脲耐药或不耐受的真性红细胞增多症患者
摘要不可用
更新日期:2022-05-18
中文翻译:
鲁索替尼用于对羟基脲耐药或不耐受的真性红细胞增多症患者
摘要不可用